Eastman Chemical Co: director James J O'Brien received 480 shares

What happened James J O'Brien, a director, was credited with 480 phantom stock units under the directors' deferred compensation plan on Oct 7, 2026. The filing reports an acquisition price of $0.00 per unit and a total value of $0 (derivative).

Key details

• Transaction date and type: Oct 7, 2026; award/grant (code A).
• Price: $0.00 per unit; number of units: 480.
• Shares owned after the transaction: not stated in the provided filing.
• Footnotes from the filing:
  • F1: Phantom stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director.
  • F2: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash.
  • F3: Includes units credited since Apr 8, 2026, as reinvestment of dividend equivalents for phantom shares deferred under the DDCP, including credits for accrued dividend equivalents that were made to the directors DDCP account on Oct 7, 2026.
• Filing date: Oct 9, 2026. Timeliness not indicated in the provided data.

Why it may matter

• This was an award of deferred compensation (phantom stock units), not an open-market purchase or sale.
• The units are payable only in cash after the director's service ends and include reinvested dividend equivalents and deferred retainer amounts. A filing does not show why the insider traded or why the company acted.